MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

12 Mar 2025 Evaluate
Glenmark Pharmaceuticals has informed that it attached media release titled ‘Glenmark Pharma Expands Cardiometabolic Portfolio with the Launch of Empagliflozin and its Fixed-Drug Combinations in India’.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..